Vaccination in rheumatology: Evolution of views on the problem
- Authors: Belov BS1, Sergeeva MS1, Tarasova GM1, Bukhanova DV1
-
Affiliations:
- ФГБНУ «НИИ ревматологии им. В.А. Hасоновой»
- Issue: Vol 89, No 5 (2017)
- Pages: 83-89
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32237
- DOI: https://doi.org/10.17116/terarkh201789583-89
- ID: 32237
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
B S Belov
ФГБНУ «НИИ ревматологии им. В.А. Hасоновой»Москва, Россия
M S Sergeeva
ФГБНУ «НИИ ревматологии им. В.А. Hасоновой»Москва, Россия
G M Tarasova
ФГБНУ «НИИ ревматологии им. В.А. Hасоновой»Москва, Россия
D V Bukhanova
ФГБНУ «НИИ ревматологии им. В.А. Hасоновой»Москва, Россия
References
- Ranjan P, Chakrawarty A, Kumari A, Kumar J. Immunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners. J Clin Diagn Res. 2015;9(5):OE01-4. doi: 10.7860/JCDR/2015/14147.5972
- Bernatsky S, Hudson M, Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford). 2007;46(7):1157-1160.
- Franklin J, Lunt M, Bunn D, Symmons D, Silman A. Risk and predictors of infection leading to hospitalisation in a largeprimary-care-derived cohort of patients with inflammatorypolyarthritis. Ann Rheum Dis. 2007;66(3):308-312.
- Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis underanti-TNF-alpha therapy. Rheumatology (Oxford). 2003;42(5):617-621.
- Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008;35(3):387-393.
- Wotton CJ, Goldacre MJ. Risk of invasive pneumococcal disease in people admitted to hospitalwith selected immune-mediated diseases: record linkage cohortanalyses. J Epidemiol Community Health. 2012;66(12):1177-1181. doi: 10.1136/jech-2011-200168
- Полянская М.В. Пневмония у пациентов с ревматическими заболеваниями: частота встречаемости, клиническая картина, факторы риска: автореф. дис. … канд. мед. наук. М., 2009.
- Пневмо-23. Инструкция по применению, противопоказания и состав. Режим доступа: http://www.rlsnet.ru/tn_index_id_249.htm
- Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis comparedwith controls: a population-based study. Arthritis Rheum. 2002;46(9):2287-2293.
- Koivuniemi R, Leirisalo-Repo M, Suomalainen R, Piirainen H, Paimela L. Infectious causes of death in patients with rheumatoid arthritis: an autopsy study. Scand J Rheumatol. 2006;35(4):273-276.
- Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37(4): 481-494.
- Yazici Y, Curtis JR, Ince A, Baraf H, Malamet RL, Teng LL, Kavanaugh A. Efficacy of tocilizumab in patients with moderate to severe activerheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study. Ann Rheum Dis. 2012;71(2):198-205. doi: 10.1136/ard.2010.148700
- Lanternier F, Henegar C, Mouthon L, Blanche P, Guillevin L, Launay O. Low influenza-vaccination rate among adults receivingimmunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis. 2008;67(7):1047. doi: 10.1136/ard.2007.081703
- Pradeep J, Watts R, Clunie G. Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66(6):837-838.
- Dougados M1, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, El-Zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study(COMORA). Ann Rheum Dis. 2014;73(1):62-68. doi: 10.1136/annrheumdis-2013-204223
- Медуницын Н.В.Вакцинология. 2-е изд., перераб. и доп. М.: Триада-Х; 2004.
- Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother. 2004;58(5):325-337.
- Bach JF. Protective role of infections and vaccinations on autoimmune diseases. J Autoimmun. 2001;16(3):347-353.
- Levitsky LL. Childhood immunizations and chronic illness. N Engl J Med. 2004;350(14):1380-1382.
- Brodman R, Gilfillan R, Glass D, Schur PH. Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med. 1978;88(6):735-740.
- Herron A, Dettleff G, Hixon B, Brandwin L, Ortbals D, Hornick R, Hahn B. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA. 1979;242(1):53-56.
- Louie JS, Nies KM, Shoji KT, Fraback RC, Abrass C, Border W, Cherry JD, Imagawa D. Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med. 1978;88(6):790-792.
- Ristow SC, Douglas RG Jr, Condemi JJ. Influenza vaccination of patients with systemic lupus erythematosus. Annals of internal medicine. 1978;88(6):786-789.
- Williams GW, Steinberg AD, Reinertsen JL, Klassen LW, Decker JL, Dolin R. Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med. 1978;88(6):729-734.
- Croft SM, Schiffman G, Snyder E, Herrmann K, James K, Jarrett MP. Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus. J Rheumatol. 1984;11(2):141-146.
- Battafarano DF, Battafarano NJ, Larsen L, Dyer PD, Older SA, Muehlbauer S, Hoyt A, Lima J, Goodman D, Lieberman M, Enzenauer RJ. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum. 1998;41(10):1828-1834.
- Mercado U. Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus? The Journal of rheumatology. 2006;33(8):1469-1471.
- Kaine JL, Kivitz AJ, Birbara C, Luo AY. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritisreceiving adalimumab. J Rheumatol. 2007;34(2):272-279.
- Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006;45(1):106-111.
- Mori S, Ueki Y, Akeda Y, Hirakata N, Oribe M, Shiohira Y, Hidaka T, Oishi K. Pneumococcal polysaccharide vaccination in rheumatoid arthritispatients receiving tocilizumab therapy. Ann Rheum Dis. 2013;72(8):1362-1366. doi: 10.1136/annrheumdis-2012-202658
- Bingham CO 3d, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum. 2010;62(1):64-74. doi: 10.1002/art.25034
- Hua C, Barnetche T, Combe B, Morel J. Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2014;66(7):1016-1026. doi: 10.1002/acr.22246
- Kapetanovic M, Saxne T, Jönsson G, Truedsson L, Geborek P. Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis. Arthritis Res Ther. 2013;15(5):R171. doi: 10.1186/ar4358
- Schiff M. Response to pneumococcal vaccine in rheumatoid arthritis patients with an inadequate response to anti-TNF therapy treated with abatacept in the arrive trial. Annals of the rheumatic diseases. 2007;66(Suppl.II):437.
- Pham T. Abatacept therapy and safety management Joint, bone, spine: revue du rhumatisme. 2009;76(Suppl.1):3-84.
- Winthrop KL, Silverfield J, Racewicz A, Neal J, Lee EB, Hrycaj P, Gomez-Reino J, Soma K, Mebus C, Wilkinson B, Hodge J, Fan H, Wang T, Bingham CO 3rd. The effect of tofacitinib on pneumococcal and influenza vaccineresponses in rheumatoid arthritis. Ann Rheum Dis. 2016;75(4):687-695. doi: 10.1136/annrheumdis-2014-207191
- Crnkic Kapetanovic M, Saxne T, Truedsson L, Geborek P. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritistreated with different antirheumatic drugs. Arthritis Res Ther. 2013;15(1):R1. doi: 10.1186/ar4127
- Plotkin SA. Correlates of protection induced by vaccination. Clinical and vaccine immunology. 2010;17(7):1055-1065.
- Kavanaugh A. Infection prophylaxis in antirheumatic therapy: emphasis on vaccination. Curr Opin Rheumatol. 2009;21(4):419-424. doi: 10.1097/BOR.0b013e328329ec6e
- van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011;70(3):414-422. doi: 10.1136/ard.2010.137216
- Binymin K, Cooper RG. Late reactivation of spinal tuberculosis by low-dose methotrexatetherapy in a patient with rheumatoid arthritis. Rheumatology (Oxford). 2001;40(3):341-342.
- McMahan ZH, Bingham CO 3rd. Effects of biological and non-biological immunomodulatory therapieson the immunogenicity of vaccines in patients with rheumaticdiseases. Arthritis Res Ther. 2014;16(6):506. doi: 10.1186/s13075-014-0506-0
- Salemi S, D’Amelio R. Are anti-infetious vaccinations safe and effective in patients with autoimmunity? Int Rev Immunol. 2010;29(3):270-314. doi: 10.3109/08830185.2010.483028
- Bengtsson C, Kapetanovic MC, Källberg H, Sverdrup B, Nordmark B, Klareskog L, Alfredsson L; EIRA Study Group. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. AnnRheumDis. 2010;69(10):1831-1833. doi: 10.1136/ard.2010.129908
- Костинов М.П., Тарасова А.А. Вакцинопрофилактика пневмококковой инфекции и гриппа при аутоиммунных заболеваниях. М.: МДB; 2009.
- Наумцева М.С. Оценка иммуногенности и безопасности 23-валентной полисахаридной пневмококковой вакцины у больных ревматоидным артритом: автореф. дис. … канд. мед. наук. М.; 2016.
- Bijl M, Agmon-Levin N, Dayer JM, Israeli E, Gatto M, Shoenfeld Y. Vaccination of patients with auto-immune inflammatory rheumaticdiseases requires careful benefit-risk assessment. Autoimmun Rev. 2012;11(8):572-576. doi: 10.1016/j.autrev.2011.10.015
- Ferreira I, Isenberg D. Vaccines and biologics. Annals of the rheumatic diseases. 2014;73(8):1446-1454.
- Perry LM, Winthrop KL, Curtis JR. Vaccinations for rheumatoid arthritis Current rheumatology reports. 2014;16(8):431.
Supplementary files
